BAÜMER Surgical Gowns (COP01, COP04, COP05, COP10)
Hindernis DE Mexico, S.A.P.I. DE C.V. · Decision date May 12, 2026
What did the FDA decide?
FDA records K260725 as a 510(k) premarket notification, with a decision dated May 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- May 12, 2026
Regulatory record facts
- Identifier
- K260725
- Regulatory pathway
- 510(k) premarket notification
- Product code
- FYA
- Decision code
- SESE
- Decision date
- May 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Gown, Surgical.
- Product code
- FYA
- FDA device class
- 2
FDA decision timeline
K260725 received
Application receipt date recorded by FDA.
K260725 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FYA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Principle & Will Co., Ltd. | 510(k) clearance | Aug 26, 2026 | FDA | |
| Yadu Medical (Henan) Co., Ltd. | 510(k) clearance | Aug 7, 2026 | FDA | |
| New York Embroidery Studio | 510(k) clearance | Jul 10, 2026 | FDA | |
| New York Embroidery Studio (NYES) | 510(k) clearance | Jun 4, 2026 | FDA | |
| Cardinal Health 200, LLC | 510(k) clearance | Apr 28, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hindernis DE Mexico, S.A.P.I. DE C.V.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Naucalpan De Juarez
Sources and methodology
- Original FDA record: K260725
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

